MacKay-Dunn R. Hector 4
4 · Aurinia Pharmaceuticals Inc. · Filed May 13, 2021
Insider Transaction Report
Form 4
MacKay-Dunn R. Hector
Director
Transactions
- Purchase
Common Stock
2021-05-11$11.14/sh+1,000$11,140→ 3,000 total - Purchase
Common Stock
2021-05-11$11.17/sh+500$5,585→ 2,000 total - Purchase
Common Stock
2021-05-12$11.28/sh+1,600$18,040→ 6,000 total - Purchase
Common Stock
2021-05-12$11.26/sh+1,400$15,764→ 4,400 total